CbdMD Historical Financial Ratios
| YCBD Stock | USD 0.49 0.02 3.92% |
CbdMD is presently reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.0942, Dividend Yield of 1.66, PTB Ratio of 0.25 or Days Sales Outstanding of 20.08 will help investors to properly organize and evaluate cbdMD Inc financial condition quickly.
CbdMD |
About CbdMD Financial Ratios Analysis
cbdMD IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CbdMD investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CbdMD financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CbdMD history.
CbdMD Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing cbdMD Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CbdMD sales, a figure that is much harder to manipulate than other cbdMD Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is cbdMD Inc dividend as a percentage of CbdMD stock price. cbdMD Inc dividend yield is a measure of CbdMD stock productivity, which can be interpreted as interest rate earned on an CbdMD investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to cbdMD Inc. There are two different methods for calculating cbdMD Inc invested capital: operating approach and financing approach. Understanding CbdMD invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from CbdMD's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into cbdMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At present, CbdMD's Payables Turnover is projected to slightly decrease based on the last few years of reporting. The current year's Interest Coverage is expected to grow to 2,083, whereas PTB Ratio is forecasted to decline to 0.25.
| 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.3 | 1.76 | 1.59 | 1.66 | Price To Sales Ratio | 0.38 | 0.0862 | 0.0992 | 0.0942 |
CbdMD fundamentals Correlations
Click cells to compare fundamentals
CbdMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CbdMD fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.11 | 2.57 | 0.38 | 0.0862 | 0.0992 | 0.0942 | |
| Days Sales Outstanding | 7.94 | 9.14 | 14.93 | 18.38 | 21.13 | 20.08 | |
| Book Value Per Share | 80.72 | 84.48 | 23.67 | 4.47 | 4.02 | 3.82 | |
| Operating Cash Flow Per Share | (10.87) | (11.54) | (11.27) | (2.13) | (1.91) | (2.01) | |
| Average Payables | 1.8M | 2.9M | 2.9M | 2.0M | 1.8M | 1.6M | |
| Stock Based Compensation To Revenue | 0.0487 | 0.0658 | 0.0262 | 0.0142 | 0.0163 | 0.0155 | |
| Capex To Depreciation | 4.31 | 1.83 | 1.04 | 0.23 | 0.1 | 0.12 | |
| Ev To Sales | 1.96 | 2.11 | 0.33 | 0.16 | 0.19 | 0.18 | |
| Free Cash Flow Per Share | (12.22) | (13.46) | (11.79) | (2.27) | (2.05) | (2.15) | |
| Roic | (0.25) | (0.18) | 1.2 | (1.03) | (0.92) | (0.88) | |
| Inventory Turnover | 3.37 | 2.89 | 3.07 | 2.26 | 2.6 | 2.47 | |
| Net Income Per Share | 12.85 | (19.16) | (55.8) | (11.34) | (10.21) | (10.72) | |
| Days Of Inventory On Hand | 108.3 | 126.46 | 118.88 | 161.19 | 145.07 | 101.7 | |
| Payables Turnover | 5.44 | 4.87 | 6.42 | 4.81 | 5.54 | 5.62 | |
| Capex To Revenue | 0.0315 | 0.0527 | 0.0195 | 0.0123 | 0.0142 | 0.0135 | |
| Cash Per Share | 15.4 | 22.48 | 5.81 | 0.89 | 1.02 | 0.97 | |
| Pocfratio | (8.28) | (8.11) | (0.9) | (0.48) | (0.44) | (0.46) | |
| Capex To Operating Cash Flow | (0.12) | (0.17) | (0.046) | (0.0692) | (0.0795) | (0.0835) | |
| Pfcf Ratio | (7.37) | (6.95) | (0.86) | (0.45) | (0.41) | (0.43) | |
| Days Payables Outstanding | 67.06 | 75.01 | 56.89 | 75.81 | 87.19 | 87.04 | |
| Income Quality | (0.85) | 0.6 | 0.21 | 0.19 | 0.17 | 0.18 | |
| Roe | 0.16 | (0.23) | (2.36) | (2.54) | (2.29) | (2.4) | |
| Ev To Operating Cash Flow | (7.7) | (6.66) | (0.77) | (0.92) | (0.83) | (0.87) | |
| Pe Ratio | 7.01 | (4.88) | (0.18) | (0.0908) | (0.0817) | (0.0858) | |
| Return On Tangible Assets | 0.36 | (0.52) | (3.23) | (1.77) | (2.03) | (2.13) | |
| Ev To Free Cash Flow | (6.85) | (5.72) | (0.74) | (0.86) | (0.78) | (0.82) | |
| Earnings Yield | 0.14 | (0.2) | (5.51) | (11.01) | (12.66) | (12.03) | |
| Intangibles To Total Assets | 0.69 | 0.64 | 0.44 | 0.2 | 0.18 | 0.17 | |
| Net Debt To E B I T D A | 0.36 | 0.92 | 0.12 | (0.25) | (0.29) | (0.28) | |
| Current Ratio | 3.08 | 5.28 | 3.03 | 1.73 | 1.56 | 3.09 | |
| Tangible Book Value Per Share | 2.93 | 19.13 | 10.24 | 2.87 | 2.59 | 2.72 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.90) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.